Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Oxford Health Plan (OXHP) -- Ignore unavailable to you. Want to Upgrade?

To: men mailman who wrote (374)	12/8/1997 6:39:00 PM
From: Michael Burry	Read Replies (1) \| Respond to of 2068

SmartMoney Interactive put out this headline today during trading hours: FORGET OXFORD HEALTHCARE, TRY BIOCHEM PHARMA The story isn't even about Oxford in the slightest - just how one manager is turning his back entirely on HMO's because of Oxford's disappointment. A good contrarian sign. Note that in the latest Barron's which starts with the teaser, "Ever wonder what makes institutions pull billions from stocks?," the top two of three issues are earnings disappointments and analyst downgrades/upgrades. Looks like Wall Street is just turning its back here. Volumes are getting inflated by traders and the fact it is the Nasdaq, creating the false appearance that big institutions are still around. In it for the long haul, Mike